07.01.2013 Views

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Program#/Poster#: 291.29/SS12<br />

Topic: F.02.j. Learning and memory: Pharmacology<br />

Support: Abbott Laboratories<br />

<strong>Title</strong>: Improvement of sensory gating by the histamine H3 antagonist ABT-239 is blocked by the<br />

muscarinic antagonist scopolamine<br />

Authors: *H. ROBB, R. S. BITNER, J. D. BRIONI, R. J. RADEK;<br />

Neurosci. Res., Abbott Labs, Abbott Park, IL<br />

<strong>Abstract</strong>: ABT-239 is an H3 receptor antagonist that improves sensory gating in DBA/2 mice.<br />

Gating is a processing function of the CNS that filters redundant sensory in<strong>for</strong>mation and is<br />

deficient in schizophrenic patients. H3 antagonists increase extracellular histamine and<br />

acetylcholine (ACh), which may mediate the effects of ABT-239 on sensory gating. To<br />

investigate this, we attempted to block the effects of ABT-239 on sensory gating in mice with<br />

antagonists of histamine and ACh receptors. Sensory gating was assessed by recording<br />

hippocampal evoked potential (EP) EEG in freely moving DBA/2 mice. EPs were elicited with<br />

pairs of auditory clicks, and gating ratios were calculated by dividing the amplitude of the second<br />

EP (click 2) by the amplitude of the first EP (click 1). In the first study, the histamine H1 receptor<br />

antagonist diphenhydramine (10.0 mg base/kg) failed to block the effect of ABT-239 (3.0 mg/kg<br />

i.p.) to lower gating ratio and improve gating. An ACh receptor mechanism was investigated by<br />

pretreating animals with either the nicotinic ACh receptor antagonist mecamylamine (MEC, 5.0<br />

κmol/kg), or the muscarinic ACh receptor antagonist scopolamine (SCOP, 1.0 mg base/kg).<br />

SCOP, but not MEC, blocked the effects of ABT-239 to improve gating. In summary, these<br />

studies suggest that the effect of ABT-239 on sensory gating is mediated by muscarinic ACh<br />

receptors, but not nicotinic ACh or histamine H1 receptors.<br />

Disclosures: H. Robb, Abbott Laboratories, A. Employment (full or part-time); R.S. Bitner,<br />

Abbott Laboratories, A. Employment (full or part-time); J.D. Brioni, Abbott Laboratories, A.<br />

Employment (full or part-time); R.J. Radek, Abbott Laboratories, A. Employment (full or parttime).<br />

Poster<br />

291. Animal Cognition and Behavior: Learning and Memory: Pharmacology II<br />

Time: Sunday, November 16, 2008, 1:00 pm - 5:00 pm<br />

Program#/Poster#: 291.30/SS13<br />

Topic: F.02.j. Learning and memory: Pharmacology

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!